FDA Prescription Drug Abuse Summary Reports
Ended Master IDIQ Awarded
- Federal agency
-
Food and Drug Administration
- Awardees
- 2
- Task orders
- 13
- Obligated
- $4,604,632
Vehicle facts
- Opportunity
-
- FDARFP1168334 Solicitation number
- Agency
-
- Food and Drug Administration Department of Health and Human Services
- Combined task order value
- $4,604,632 Current and potential, with all options
- Last date to order 100% complete
- Shared ceiling 46% used
- $10,000,000.00
IDV award and task order details come from SAM.gov/FPDS.
About this vehicle
The Food and Drug Administration awarded this Master IDIQ on August 21, 2016, to provide prescription drug abuse summary reports to the Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology. The vehicle is no longer active — ordering closed on August 23, 2018, more than seven years ago. The $10 million shared ceiling and all 13 task orders issued under the vehicle are now complete; the most recent order was placed in September 2020 and obligated $4.6 million total across its life.
Work centered on post-marketing surveillance data for prescription and over-the-counter drug abuse, with task orders funding drug-specific reports on opioid and fentanyl abuse patterns, treatment-center program data quality and representativeness, data enhancement projects, and epidemiological monitoring. Task orders ranged from $33,403 to $1.095 million, with most clustering in the $38,000 to $816,000 band. The FDA was the sole customer agency.
Competition was limited to two primes. Inflexxion, Inc. won five orders valued at $2.8 million combined; Denver Health and Hospital Authority won eight orders valued at $1.8 million. All 13 task orders were unrestricted (no set-aside), with firm fixed pricing. Task orders covered one to three years of performance, with most spanning 12 to 24 months. By September 2020, ordering activity had slowed considerably — the vehicle averaged four orders per year in 2016–2017, declining to one order in 2020 before the vehicle closed to new task orders.
This vehicle is closed to pursuit. No new ordering is possible.
Description
The purpose of this solicitation is to obtain a contract which provides prescription drug abuse summary reports to the U.S. Food and Drug Administration ("FDA"), Center for Drug Evaluation and Research ("CDER"), Office of Surveillance and Epidemiology ("OSE"). In turn, OSE will use the reports to help inform pharmaceutical regulatory and oversight efforts, and abuse prevention programs.
IDV awards
| Awardee | IDV award | Awarded |
|---|---|---|
| Inflexxion, Inc. | HHSF223201610027I | |
| Denver Health And Hospital Authority | HHSF223201610028I |
Latest task orders
Show all 13
Top awardees by obligations
| Rank | Awardee | Obligated | Share |
|---|---|---|---|
| 1 | Inflexxion, Inc. | $2,789,472 | 61% |
| 2 | Denver Health And Hospital Authority | $1,815,160 | 39% |
Top funding agencies by obligations
| Rank | Funding agency | Obligated | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $4,604,632 | 100% |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2026 | -$44 |
| FY2023 | -$6,315 |
| FY2022 | -$12,832 |
| FY2021 | -$6,644 |
| FY2020 | $297,594 |
| FY2019 | $2,122,457 |
| FY2018 | $359,459 |
| FY2017 | $1,408,701 |
| FY2016 | $442,256 |
Quick answers
What is the FDA Prescription Drug Abuse Summary Reports contract vehicle?
FDA Prescription Drug Abuse Summary Reports is an indefinite delivery, indefinite quantity (IDIQ) contract vehicle run by Food and Drug Administration (Department of Health and Human Services), awarded on August 21, 2016.
Which companies hold FDA Prescription Drug Abuse Summary Reports?
2 companies hold FDA Prescription Drug Abuse Summary Reports's IDV awards, one each. The latest went to Inflexxion, Inc. on August 21, 2016. The awardees whose task orders obligated the most are Inflexxion, Inc. and Denver Health And Hospital Authority.
How much has been spent through FDA Prescription Drug Abuse Summary Reports?
13 task orders have been placed under FDA Prescription Drug Abuse Summary Reports, obligating $4,604,632.
What is the shared ceiling of FDA Prescription Drug Abuse Summary Reports?
FDA Prescription Drug Abuse Summary Reports's shared ceiling is $10,000,000; its task orders have used 46% of it.
Which agencies use FDA Prescription Drug Abuse Summary Reports the most?
The departments whose task orders under FDA Prescription Drug Abuse Summary Reports obligated the most are Department of Health and Human Services ($4,604,632).
On GovTribe
See this vehicle's full record
- Every IDV award and task order
- Funding by agency, awardee, NAICS and set-aside
- Teaming partners on this vehicle
- Ask GovTribe AI about this vehicle